Pfizer Executive Andrew Baum to Shift to Advisory Role, Plans Exit by Year-End
Andrew Baum, who joined Pfizer in 2024 as Chief Strategy and Innovation Officer, will move into a senior strategic advisor role to CEO Albert Bourla and is expected to depart the company by the end of the year. A BMO Capital Markets note frames the change as part of ongoing operational simplification rather than a major strategic redirection.